Replies to post #311993 on Amarin Corp Plc (AMRN)

[rafunrafun]

O - I sent your post to my expert friend and will post his opinion once I have it.

My guess is that unless NY has become a total totalitarianism, the pharmacist is incorrect. You have a prescription. Both products are applicable. How in the friggin hell are you forbidden from having the right to chooce, especially since V is cheaper?!

I would ask him to disclose the kickbacks that he / pharmacy receive from generics.

Two more things:

What was your price for gV / V (when you received it)?

Please also do the freezer test - put both pills in the freezer until they freeze and see which is more clear - I think they'll be nearly identical, but the smell is where you'll see (smell) the difference.

Thank you.

[rosemountbomber]

The guy is correct in saying he doesn’t know what you are taking it for. Good luck with your doc on Monday.

[ziploc_1]

One...QUOTE ". He(i.e. the pharmacist) stated he did not know what I was taking if for and when the generic states it is an exact replacement that he has no other choice then to change me to the generic."

If this is the case, Amarin needs to introduce their authorized generic Vascepa ASAP, even before their legal cases against Hikma are adjudicated. If Amarin prevails in these cases, it can withdraw their authorized generic Vascepa from the market...This will have several advantages:

1.it will give patients real Vascepa instead of adulterated gV
2. patients who are encouraged by the many benefits of the real Vascepa, will be more inclined to ask for it
3.it will reduce profits for Hikma
4. the low volume of sales for Hikma will make Hikma's API prices even higher
6. it will satisfy Amarin's existing commitments to buy a large amount of supply of API and finished product
7. it will encourage Hikma's current suppliers to switch to supplying Amarin
8. it help to keep Amarin cash flow positive while legal cases are in progress.

[alwayswatching1]

NEW YORK enough said...